Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H20F4N8O2 |
Molecular Weight | 528.4616 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC1=NC=CN1C2=CC=C(NC(=O)C3=CC(=NN3C4=CC5=C(ON=C5N)C=C4)C(F)(F)F)C(F)=C2
InChI
InChIKey=OFJRNBWSFXEHSA-UHFFFAOYSA-N
InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)
Molecular Formula | C24H20F4N8O2 |
Molecular Weight | 528.4616 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Razaxaban (also known as BMS-561389 or DPC 906) is an oral factor Xa inhibitor that was being developed for the treatment of thrombosis. It showed excellent results in the lab for efficacy and bioavailability and was therefore selected for further development. In a phase 1 clinical trial with healthy subjects, Razaxaban was well tolerated with minor bleeding. However, higher bleeding was reported in thrombosis patients in a phase 2 clinical trial, and the development of this drug was therefore discontinued in 2005.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:13:37 GMT 2023
by
admin
on
Fri Dec 15 17:13:37 GMT 2023
|
Record UNII |
3K2509846L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C263
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8445
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
300000036988
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
3K2509846L
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
C84134
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
C500057
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
204102
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL206335
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY | |||
|
218298-21-6
Created by
admin on Fri Dec 15 17:13:37 GMT 2023 , Edited by admin on Fri Dec 15 17:13:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|